Butabarbital decreases consequences of sufentanil SL by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Modify Therapy/Check Intently. Coadministration of CYP3A4 inducers may lessen sufentanil stages and efficacy, possibly precipitating withdrawal syndrome in patients who've produced physical dependence to sufentanil. Discontinuation of concomitantly used CYP3A4 inducers may ... https://sidneyb578wza3.popup-blog.com/profile